These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17340621)

  • 1. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
    Chhipa RR; Bhat MK
    J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells.
    Park JB; Lee JK; Cho ST; Park EY; Riew KD
    Eur Spine J; 2007 Sep; 16(9):1319-24. PubMed ID: 17684774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
    Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
    Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas.
    Ciccolini J; Fina F; Bezulier K; Giacometti S; Roussel M; Evrard A; Cuq P; Romain S; Martin PM; Aubert C
    Mol Cancer Ther; 2002 Sep; 1(11):923-7. PubMed ID: 12481413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.
    Shi LY; Han Z; Li XX; Li M; Han H; Chen J; Zang S
    Cancer Biother Radiopharm; 2015 Feb; 30(1):33-40. PubMed ID: 25517620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Oncol Rep; 2003; 10(6):1925-30. PubMed ID: 14534720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclasts direct bystander killing of cancer cells in vitro.
    Ramnaraine M; Pan W; Clohisy DR
    Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
    Radin D; Lippa A; Patel P; Leonardi D
    Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
    Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New compound NL-608 (a nutlin analog) induces apoptosis in human breast cancer MCF-7 cells].
    Ge YK; Zhang YX; Chen YP; Bai X; Shi W
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):100-3. PubMed ID: 22780926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
    Hyer ML; Sudarshan S; Schwartz DA; Hannun Y; Dong JY; Norris JS
    Cancer Gene Ther; 2003 Apr; 10(4):330-9. PubMed ID: 12679806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.